|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Genmark Diagnostics, Inc. (GNMK) |
|
|
$24.04 0.00 (0.00%) as of 4:30 Tue 4/20
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
71,720,000 |
| Market
Cap: |
1.72(B) |
| Last
Volume: |
8,115 |
Avg
Vol: |
8,092 |
| 52
Week Range: |
$24.04 - $24.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stier Eric |
SVP & General Counsel |
• – – |
2021-02-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,208) |
290,616 |
|
- |
|
| Stier Eric |
SVP & General Counsel |
• – – |
2021-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,337) |
292,824 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,070) |
280,426 |
|
- |
|
| Mendel Scott |
President & CEO |
• • – |
2021-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,860) |
552,286 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-02-22 |
4 |
AS |
$20.36 |
$5,904 |
D/D |
(290) |
281,496 |
|
21% |
|
| Obrien Scott Alexander |
SVP, Global Mktg & Intl Sales |
• – – |
2021-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(390) |
182,075 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(434) |
230,785 |
|
- |
|
| Ek John Frederick |
Chief Financial Officer |
• – – |
2021-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(487) |
253,149 |
|
- |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2021-02-19 |
4 |
S |
$21.80 |
$51,012 |
D/D |
(2,340) |
414,388 |
|
-16% |
|
| Winkler Sarah Hollis |
VP, Human Resources |
• – – |
2021-02-19 |
4 |
S |
$21.80 |
$14,257 |
D/D |
(654) |
158,683 |
|
-16% |
|
| Obrien Scott Alexander |
SVP, Global Mktg & Intl Sales |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
182,465 |
|
- |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
416,728 |
|
- |
|
| Stier Eric |
SVP & General Counsel |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
294,161 |
|
- |
|
| Stier Eric |
SVP & General Counsel |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,208) |
275,411 |
|
- |
|
| Shaw Christine |
VP, Assay Development |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
106,046 |
|
- |
|
| Ek John Frederick |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
253,636 |
|
- |
|
| Ek John Frederick |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,622) |
208,636 |
|
- |
|
| Mendel Scott |
President & CEO |
• • – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
80,070 |
554,146 |
|
- |
|
| Mendel Scott |
President & CEO |
• • – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,952) |
474,076 |
|
- |
|
| Chohan Abdul |
SVP Operations |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
63,750 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
281,786 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,820) |
259,286 |
|
- |
|
| Harkins Michael John |
SVP, Sales |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
155,992 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
231,219 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,628) |
212,469 |
|
- |
|
854 Records found
|
|
Page 3 of 35 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
